Doctor Kristina Kopeva
Cardiology Research Institute, Tomsk NRMC, Tomsk (Russian Federation)
Pharmacogenetics of therapy effectiveness for anthracycline-induced cardiotoxicity
Event: ESC Congress 2021 - The Digital Experience
Topic: Cardio-Oncology
Session: Cardiovascular Disease in Special Populations ePosters
Anthracycline-induced cardiotoxicity: the role of endothelial dysfunction
Event: Heart Failure 2021
Topic: Cardiotoxicity of Drugs and Other Therapies
Session: ePoster session
Prognostic value of soluble ST2 biomarker in heart failure patients with obstructive sleep apnea syndrome
Event: EuroHeartCare - ACNAP Congress 2021
Topic: Allied Professions in Cardiovascular Care
Session: ePosters
Anthracycline-Induced Cardiotoxicity: predictors for risk assessment in women without cardiovascular diseases
Event: ESC Preventive Cardiology 2021
Topic: Biomarkers
Session: Moderated abstracts - Secondary Prevention and Rehabilitation
Prognostic role of ST2 in heart failure patients with carbohydrate metabolism disorders
Event: Heart Failure 2019
Topic: Pathophysiology
Session: Chronic Heart Failure – Pathophysiology and Mechanisms
Prognostic value of soluble ST2 biomarker in heart failure patients with preserved ejection fraction
Event: ESC Congress 2018
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Session: Chronic heart failure – pathophysiology and mechanisms
ESC 365 is supported by
